These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 6312394

  • 41. [Study of clinical bacteriological efficacy in a cefmenoxime ototopical solution].
    Deguchi K, Fukayama S, Nishimura Y, Nishike A, Oda S, Sato S, Matsumoto Y, Ikegami R, Yokota N, Tanaka S.
    Jpn J Antibiot; 1985 Jul; 38(7):1739-49. PubMed ID: 3906166
    [Abstract] [Full Text] [Related]

  • 42. [In vitro antibacterial activity of ciprofloxacin against uropathogenic organisms].
    Allocati N, Catamo G, Cellini L.
    Boll Soc Ital Biol Sper; 1984 Oct 30; 60(10):1927-33. PubMed ID: 6440583
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Antimicrobial susceptibility tests with cefotaxime and correlation with clinical bacteriologic response.
    Thornsberry C, Jones RN, Barry AL, Fuchs PC.
    Rev Infect Dis; 1982 Oct 30; 4 Suppl():S316-24. PubMed ID: 6294780
    [Abstract] [Full Text] [Related]

  • 45. Antimicrobial activity of cefmenoxime (SCE-1365).
    Stamm JM, Girolami RL, Shipkowitz NL, Bower RR.
    Antimicrob Agents Chemother; 1981 Mar 30; 19(3):454-60. PubMed ID: 6264846
    [Abstract] [Full Text] [Related]

  • 46. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L, Le Van Thoi J, Soussy CJ, Duval J.
    Pathol Biol (Paris); 1982 Jun 30; 30(6):363-9. PubMed ID: 6810282
    [Abstract] [Full Text] [Related]

  • 47. [In vitro antibacterial activity of ceftizoxime on Pasteurella and EF4].
    Escande F, Ghanassia JP.
    Pathol Biol (Paris); 1987 May 30; 35(5):531-4. PubMed ID: 3302857
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. In vitro studies of tigemonam: a comparison of the minimum inhibitory and minimum bactericidal concentrations (MIC vs MBC).
    Gobernado M, Cantón E.
    J Chemother; 1989 May 30; 1 Suppl 2():36-40. PubMed ID: 2809701
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Influence of different Mueller-Hinton agars and media age on Etest susceptibility testing of tigecycline.
    Tan TY, Ng LS, Chen DM.
    Diagn Microbiol Infect Dis; 2010 Sep 30; 68(1):93-5. PubMed ID: 20727479
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [Comparison of the in vitro antibacterial activity of ofloxacin and nalidixic acid].
    Hasçelik G, Baykal M.
    Mikrobiyol Bul; 1990 Jul 30; 24(3):251-5. PubMed ID: 2283977
    [Abstract] [Full Text] [Related]

  • 57. Comparative in vitro activities of cefmenoxime (SCE-1365) and newer cephalosporin derivatives of clinical utility.
    Ahonkhai VI, Cherubin CE, Shulman MA, Bancroft U.
    Antimicrob Agents Chemother; 1982 Jun 30; 21(6):999-1002. PubMed ID: 6287933
    [Abstract] [Full Text] [Related]

  • 58. In vitro activity of cefmenoxime, cefotaxime, latamoxef, cefazolin, nafcillin and vancomycin against 53 endocarditis and bacteremic strains of Staphylococcus aureus.
    Dhawan VK, Maier MK, Nayyar M, Chuah SK, Thadepalli H.
    Chemotherapy; 1984 Jun 30; 30(5):328-30. PubMed ID: 6092007
    [Abstract] [Full Text] [Related]

  • 59. [Influence of technical factors in the determination of minimal inhibitory concentration by microdilution].
    Forey F, Coulet M, Brun Y, Fleurette J.
    Pathol Biol (Paris); 1985 May 30; 33(5):341-9. PubMed ID: 3162138
    [Abstract] [Full Text] [Related]

  • 60. In-vitro activity of BMY 28142, a new aminothiazolyl cephalosporin.
    Steele JC, Edwards BH, Rissing JP.
    J Antimicrob Chemother; 1985 Oct 30; 16(4):463-8. PubMed ID: 3840799
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.